Results 141 to 150 of about 26,462 (230)

Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease. [PDF]

BMC Cardiovasc Disord, 2022
Zhang YJ, Li DJ, Li ZY, Hu XL, Li H, Ma QL, Chen XP.   +6 more
europepmc   +1 more source

Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel. [PDF]

Clin Transl Sci, 2022
Schilling U, Hsin CH, Delahaye S, Krause A, Wuelfrath H, Halabi A, Dingemanse J.   +6 more
europepmc   +1 more source

Antiplatelet Activity of Tetramethylpyrazine via Regulation of the P2Y12 Receptor Downstream Signaling Pathway. [PDF]

Evid Based Complement Alternat Med, 2022
Guan B, Gao J, Tan Y, Ma X, Shi D.
europepmc   +1 more source

Neurotransmitter signaling in white matter [PDF]

, 2014
Butt, Arthur M., Fern, Robert F., Matute, Carlos   +2 more
core   +1 more source

Discordance in tests used to detect inhibition of the P2Y12 receptor in patients undergoing interventional neuroradiology procedures. [PDF]

Interv Neuroradiol, 2023
Gegri M, Cheves TA, Anderson MN, McTaggart R, Sweeney JD.   +4 more
europepmc   +1 more source

Increased expression of the P2Y₁₂ receptor is involved in the failure of autogenous arteriovenous fistula caused by stenosis. [PDF]

Ren Fail, 2023
Liu L, Gao J, Tang Y, Guo G, Gan H.
europepmc   +1 more source

P2Y12 and P2Y13 receptors involved in ADPβs induced the release of IL-1β, IL-6 and TNF-α from cultured dorsal horn microglia

Journal of Pain Research, 2017
Pei-Wen Liu,* Ming-Xia Yue,* Rui Zhou, Juan Niu, Du-Juan Huang, Tao Xu, Pei Luo, Xiao-Hong Liu, Jun-Wei Zeng Department of Physiology, Zunyi Medical College, Guizhou, China *These authors contributed equally to ...
Liu P, Yue M, Zhou R, Niu J, Huang D, Xu T, Luo P, Liu X, Zeng J   +8 more
doaj  

Postoperative Bleeding Risk after Gastric Endoscopic Submucosal Dissection in Patients Receiving a P2Y12 Receptor Antagonist. [PDF]

Gut Liver, 2023
Hirai R, Kawano S, Inoo S, Kuraoka S, Okanoue S, Satomi T, Hamada K, Kono Y, Kanzaki H, Iwamuro M, Kawahara Y, Okada H.   +11 more
europepmc   +1 more source

The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo. [PDF]

J Clin Med, 2021
Crescence L, Kramberg M, Baumann M, Rey M, Roux S, Panicot-Dubois L, Dubois C, Riederer MA.   +7 more
europepmc   +1 more source

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry. [PDF]

BMC Cardiovasc Disord, 2023
Kang J, Han JK, Yang HM, Park KW, Kang HJ, Koo BK, Choo EH, Lee JY, Park SD, Lim YH, Kim HM, Heo JH, Kim HS.   +12 more
europepmc   +1 more source